Drug Profile
YH 14642
Alternative Names: YH14642; YHD14642Latest Information Update: 08 Sep 2015
Price :
$50
*
At a glance
- Originator Yuhan
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Periodontitis
Most Recent Events
- 08 Sep 2015 No recent reports on development identified - Phase-II for Periodontitis in South Korea (PO)
- 29 May 2013 Yuhan Corporation completes enrolment in its phase II trial for Periodontitis in South Korea (NCT01499225)
- 31 Dec 2011 Phase-II clinical trials in Periodontitis in South Korea (PO)